BRENNER LOUIS MD (President and COO) sold 12.3% of their position (40.33K shares) of ALLENA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $32.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/17/2021ACC: 0001209191-21-065147
Officer· President and COO
Since Jan 2019
-40.33K
Net shares
Net seller
$32.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
125.58K acquired · 165.91K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−40.33K
Price / share
$0.81
Trade value
$32.67K
% of position
12.3%
11/15/2021
328.90K→288.58K
Common Stock
Direct
Shares
+125.58K
Price / share
—
Trade value
—
% of position
61.8%
11/15/2021
203.32K→328.90K
Total
Net shares
+85.25K
Net value
-$32.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/15/2021 | S · Sale | −40.33K | $0.81 | $32.67K | 12.3% | 328.90K | 288.58K |
| Common Stock Direct | 11/15/2021 | M · Option Exercise | +125.58K | — | — | 61.8% | 203.32K | 328.90K |
| Total | +85.25K | -$32.67K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
125.58K shares
Shares
−125.58K
Strike price
Held after
0.00
Exercisable
—
11/15/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock125.58K shares | 11/15/2021 | M · Option Exercise | −125.58K | — | 0.00 |